Today's Stock News: Latest Updates on Public Companies

At a glance

On October 5, 2026, Vaxcyte reported VAX-31 met all prespecified primary endpoints in its pivotal adult Phase 3 OPUS-1 trial; C.H. Robinson agreed to acquire RXO for an implied $5.8 billion; Flex announced a $2.0 billion convertible preferred investment into Axiom; Skyworks completed its combination with Qorvo.

Clinical trial and regulatory

Vaxcyte (PCVX) reported positive topline data from OPUS-1, saying VAX-31 met all prespecified primary endpoints in its pivotal adult Phase 3 pneumococcal vaccine trial, with noninferiority across shared serotypes and superiority for several unique serotypes.

Rezolute (RZLT) announced FDA recommended a pre-BLA meeting as a precursor to a potential biologics license application for ersodetug in congenital hyperinsulinism after preliminary Phase 3 sunRIZE review, despite missed primary and key secondary endpoints.

TurboGen (TRBG) entered a long-term agreement with an EU-based engineering and manufacturing provider for serial development and production of its 20kW systems, with an initial five-year term and automatic annual renewals pending development completion.

Deals and mergers

RXO (RXO) agreed to be acquired by C.H. Robinson in a stock-and-cash transaction with an implied value of $5.8 billion, with RXO holders receiving $17.25 cash plus 0.0856 C.H. Robinson shares per RXO share and closing expected in H1 2027.

Skyworks Solutions (SWKS) completed combination with Qorvo, paying Qorvo shareholders $32.50 in cash plus 0.960 Skyworks common share per Qorvo share, creating a combined company with legacy Skyworks shareholders owning ~63% and legacy Qorvo ~37%.

IES Holdings (IESC) completed acquisition of DBM Global for approximately $691 million in cash and IES common stock, comprising ~$545 million cash and 430,974 IES shares valued at ~$146 million using the Oct. 2, 2026 closing price.

Flex (FLEX) announced a convertible preferred investment as General Catalyst, Koch Equity Development and co-investors agreed to buy $2.0 billion of Axiom convertible preferred shares, valuing Axiom’s Cloud and Power Infrastructure segment at an initial enterprise value of $37.5 billion.

Harrow (HROW) closed acquisition of TYRVAYA from Viatris, paying $30 million cash and agreeing to up to $70 million in net-sales milestones for total potential consideration up to $100 million.

Financings and markets

Applied Optoelectronics (AAOI) completed its at-the-market offering, selling 5,694,845 shares at an average price of $105.36 for net proceeds of $587,999,985.89 to fund production, R&D equipment and other uses.

Pagaya Technologies (PGY) issued a AAA-rated $600 million personal loan ABS transaction (PAID 2026-6), bringing year-to-date personal loan issuance to over $6 billion and total issuance this year above $9 billion.

Neighborhood Intelligence (NXH) agreed to a registered direct offering expected to raise approximately $45.5 million gross via 16,485,508 shares or pre-funded warrants at $2.76 each plus warrants for up to 16,123,189 shares at $3.45, led by Highbridge-managed funds with management participation.

Contracts, orders and capacity

Ondas (ONDS) received an order for Electronic Safe & Arm Devices supporting a European loitering munition program for $56 million, secured through Bron Technologies and marking the first ESAD order since its GATE and Bron acquisitions.

TeraWulf (WULF) amended electric service agreement with Kentucky Power to expand contracted capacity at its Muskie Data Campus to 1 GW, moving the second 500 MW phase from 2030 to 2029 subject to regulatory approval and utility schedule.

Redwire (RDW) was awarded a follow-on contract by Axiom Space to provide Roll-Out Solar Array wings for Axiom’s second space station module, extending Redwire’s supply role across both modules ahead of the first module’s planned 2028 launch.

Aureus Greenway Holdings (PUSA) received an order for counter-unmanned aerial systems worth $82 million under an existing U.S. government IDIQ contract, with deliveries expected over the next several quarters.

Licensing and strategic collaborations

Alector (ALEC) entered a global license agreement with Genentech for AL050, receiving a $100 million upfront payment and becoming eligible for up to $1.17 billion in additional development, regulatory and commercial milestones plus tiered royalties.

Navitas Semiconductor (NVTS) collaborated with Microchip Technology to deliver an 800V reference design for AI data center rack power, targeting up to 96% peak efficiency and combining Navitas GaNFast devices with Microchip controllers and security.

Regulatory and product clearances

Alvotech (ALVO) received FDA approval to manufacture SIMLANDI drug substance in a second production suite at its Reykjavik facility, doubling U.S. manufacturing capacity and allowing commercial production in either DSM1 or DSM2.

Establishment Labs Holdings (ESTA) received FDA approval to add 28 sizes to its Motiva Implants portfolio in the U.S., expanding SmoothSilk Round and SmoothSilk Ergonomix offerings down to 105 cc and across Mini, Demi and Full profiles.

The GEO Group (GEO) completed sale of its Adelanto, California ICE processing center complex comprising three facilities and 2,644 beds for $950 million, anticipating approximately $705 million in net proceeds after taxes, fees and expenses.